BioMarin Pharmaceutical | 営業経費



Operating Expenses 変化する 日付
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
Agios Pharmaceuticals USD 139.51M 24.16M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Amgen USD 6.52B 337M 2025-06
Bayer EUR 10.73B 688M 2025-06
Biogen USD 1.79B 326.1M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
Incyte USD 904.7M 56.97M 2025-06
Insmed USD 361.29M 20.33M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Moderna USD 1.04B 113M 2025-06
Neurocrine Biosciences USD 541.9M 7M 2025-06
PTC Therapeutics USD 213.73M 7.86M 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.8B 2.03B 2025-06
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06
United Therapeutics USD 521.7M 110.1M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06


BioMarin Pharmaceutical 営業経費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Sep 2025.